Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector.
about
Enhanced atheroprotection and lesion remodelling by targeting the foam cell and increasing plasma cholesterol acceptorsStudy of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma.Helper-dependent adenoviral vectors for liver-directed gene therapy.Helper-dependent adenovirus is superior to first-generation adenovirus for expressing transgenes in atherosclerosis-prone arteriesTargeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein.Gene Therapy Targeting LDL Cholesterol but not HDL Cholesterol Induces Regression of Advanced Atherosclerosis in a Mouse Model of Familial HypercholesterolemiaSafety profile of gutless adenovirus vectors delivered into the normal brain parenchyma: implications for a glioma phase 1 clinical trialCandidate SNP Markers of Gender-Biased Autoimmune Complications of Monogenic Diseases Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene PromotersGene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model.Candidate SNP Markers of Chronopathologies Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.A rapid protocol for construction and production of high-capacity adenoviral vectors.Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression.How to Use SNP_TATA_Comparator to Find a Significant Change in Gene Expression Caused by the Regulatory SNP of This Gene's Promoter via a Change in Affinity of the TATA-Binding Protein for This Promoter.Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor.
P2860
Q28268889-66C6502D-80F7-4523-B6F0-53A0A5E454F7Q34012284-0C39213E-1D06-4663-A4DB-12381807372AQ34982825-C96E9AFA-4D5F-4028-8A56-F15F9B70C734Q34993431-5D994203-F4A3-4CC2-84CA-71C5D702BE25Q35974993-D4B16D0C-B34C-4FAF-8D6E-B82BC1FAF9DBQ36344509-8E3B63F9-B27C-4531-B012-6AE139008EAFQ36534329-2CF94FA2-1879-4ED6-B4DD-6EDC431F434EQ36760451-17630F0F-A7B9-4EE6-92FE-DE9EC1386530Q36971308-202D7A77-B17A-4E4A-BBB8-D7B5DBCC71E3Q37231785-95DBFE94-45FC-4105-8282-F9718E175004Q39859960-4E9CB87C-3072-44FA-9780-A682655E7D54Q41627013-9D8E41AD-B966-49BA-BB94-28DB0490F65AQ42179348-15B8A003-32A8-46BA-B729-4979CE5BB65CQ50102325-3F0E0A87-5F77-4FBA-A6C7-6B20ABB3E203
P2860
Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Sustained phenotypic correctio ...... r-dependent adenovirus vector.
@ast
Sustained phenotypic correctio ...... r-dependent adenovirus vector.
@en
type
label
Sustained phenotypic correctio ...... r-dependent adenovirus vector.
@ast
Sustained phenotypic correctio ...... r-dependent adenovirus vector.
@en
prefLabel
Sustained phenotypic correctio ...... r-dependent adenovirus vector.
@ast
Sustained phenotypic correctio ...... r-dependent adenovirus vector.
@en
P2093
P2860
P356
P1433
P1476
Sustained phenotypic correctio ...... r-dependent adenovirus vector.
@en
P2093
L M Belalcazar
M Finegold
P Nuno-Gonzalez
P2860
P2888
P304
P356
10.1038/SJ.GT.3302819
P577
2006-09-07T00:00:00Z